Welcome to our dedicated page for Kkr & Co news (Ticker: KKR), a resource for investors and traders seeking the latest updates and insights on Kkr & Co stock.
KKR & Co. Inc. (NYSE: KKR) is a global investment firm active across alternative asset management, capital markets and insurance solutions, and its news flow reflects this breadth. Press releases describe KKR-sponsored funds investing in private equity, credit and real assets, alongside insurance subsidiaries that offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group.
Recent KKR news highlights activity in private credit, infrastructure, real estate, digital infrastructure and transportation. For example, KKR announced the completion of a fundraise for KKR Asia Credit Opportunities Fund II and related accounts, focused on privately originated performing credit investments in Asia Pacific. The firm also reported a strategic partnership with RWE to develop UK offshore wind projects, illustrating its participation in energy transition and renewables infrastructure.
Other releases describe additional equity commitments to a European data center platform, the acquisition of a large logistics facility in Korea, and a strategic partnership to build a European rail leasing platform through an investment in Green Mobility Partners. KKR also issues updates on monetization activity, earnings release dates and fund distribution announcements, such as those related to KKR Income Opportunities Fund.
Investors and observers using this news page can review KKR’s official announcements on transactions, fund launches, capital raises, governance developments and financial disclosures. The coverage provides context on how KKR’s funds and subsidiaries operate across private equity, credit, real assets and insurance, and how the firm positions itself in themes such as private credit, digital infrastructure and the energy transition.
Gamma Biosciences announced the sale of its operating company, Mirus Bio, to Merck KGaA, Darmstadt, Germany, for $600 million in cash. The sale is expected to be completed in Q3 2024, pending regulatory approvals. Mirus Bio, acquired by Gamma in 2021, specializes in transfection solutions for genetic material delivery into cells, with applications in cell and gene therapy. Gamma's CEO, Matt Gunnison, praised Mirus' progress and expressed confidence in Merck's ability to continue this trajectory. Dale Gordon, CEO of Mirus Bio, highlighted the strengthening position in the market and future expansion under Merck. KKR representatives also emphasized their strategic growth in the life sciences sector.
On May 23, 2024, Capital Group and KKR announced an exclusive strategic partnership to develop hybrid public-private investment solutions. The collaboration aims to provide mass affluent investors with access to alternative investments, historically reserved for high-net-worth individuals. The first two strategies, focusing on public-private fixed income, are slated for a 2025 U.S. launch. Capital Group oversees $2.6 trillion, with $500 billion in public fixed income, while KKR manages over $500 billion in assets, including $200 billion in credit. This partnership leverages Capital's active management and KKR's private market expertise to create more liquid investment strategies. The global assets in alternatives are projected to grow 12% annually over the next decade.
KKR has announced the pricing of ¥91.4 billion in senior notes, split across five tranches with varying maturity dates and interest rates. The largest tranche, ¥44.6 billion, is due in 2029 with a 1.559% interest rate. Smaller tranches include ¥1 billion due in 2031 at 1.762%, ¥26.2 billion due in 2034 at 2.083%, ¥10 billion due in 2044 at 2.719%, and ¥9.6 billion due in 2054 at 3.008%. KKR intends to use the proceeds for general corporate purposes. The offering is targeted at qualified institutional buyers in the U.S. and international buyers, complying with Rule 144A and Regulation S under the Securities Act of 1933. The notes are unregistered and cannot be sold in the U.S. without proper registration or exemption. This announcement follows Rule 135c guidelines.
KKR has announced its first Global Impact investment in the Philippines with an investment in PHINMA Education. PHINMA Education is a major private higher education group in Southeast Asia, aiming to provide affordable education to underserved youth. KKR's investment comes from its Global Impact Fund II, aligning with the UN's Sustainable Development Goals, specifically SDG 4 (Quality Education). PHINMA will remain the majority shareholder. The investment aims to scale PHINMA's operations and reach more students in the region. The transaction is expected to close in Q3 2024, pending regulatory approval.
Vitesse has secured $93M in Series C funding led by KKR, with participation from existing investors such as Hannover Digital Investments. This new funding will support product development and enhance connectivity across the insurance value chain, accelerating Vitesse's mission to revolutionize global payments and treasury management.
Additionally, Curt Hess has been appointed as US Executive President, bringing extensive experience from his prior roles at 10x Banking and Barclays. This move signifies Vitesse's commitment to expanding in the US market. With a team of 177 employees, Vitesse aims to enhance its global payments network, providing real-time management and capital safeguarding for stakeholders in the insurance industry.
The investment will also see Patrick Devine from KKR joining Vitesse's board of directors. KKR's investment is made through its Next Generation Technology Growth Fund III, reflecting their strategic focus on the global insurance industry.
KKR, a global investment firm, has acquired a significant minority stake in Infinx, an AI-driven healthcare revenue cycle solutions provider. This investment aims to accelerate Infinx's growth and expand its network. Existing shareholder Norwest Venture Partners also participated. Infinx, founded in 2012, offers innovative revenue cycle management solutions, particularly in the US market, supporting 172,000 healthcare professionals across 4,000 facilities. Infinx's platform utilizes AI, automation, and payer integration. The US healthcare market is valued at $4.3 trillion, comprising over 18% of the GDP. In 2023, Infinx was recognized as a top RCM vendor by Everest Group and Black Book Research. KKR's support is expected to enhance Infinx's capabilities and market reach.
KKR announced that CFO Robert H. Lewin will present at the TD Financial Services & Fintech Summit on June 6, 2024, at 8:35 AM ET. The presentation will be accessible via a live webcast on KKR's Investor Center website, with a replay available shortly after. KKR is a global investment firm offering alternative asset management, capital markets, and insurance solutions. KKR sponsors investment funds in private equity, credit, and real assets, and its insurance subsidiaries, managed by Global Atlantic Financial Group, offer retirement, life, and reinsurance products.
KKR, a global investment firm, has provided a $300 million corporate credit facility to Origis Energy through its insurance business. This funding will support Origis' ongoing development and construction of solar and storage projects. Origis, ranked third by S&P Global Commodity Insights for planned solar installations through 2028, has a project portfolio of over 12 GW in the U.S., with an additional 13 GW in the pipeline. Vikas Anand, CEO of Origis, praised the collaboration with KKR. Sam Mencoff, Director at KKR, highlighted the strong demand for renewable energy financing. This investment is part of KKR's Asset-Based Finance strategy, which manages approximately $54 billion in assets globally.
KKR & Co. announced that Co-CEO Joseph Y. Bae will present at the Bernstein 40th Annual Strategic Decisions Conference 2024 on May 29, 2024, at 3:30 PM ET. The presentation will be webcast live via KKR's Investor Center, with a replay available shortly after. KKR, a global investment firm, focuses on alternative asset management, capital markets, and insurance solutions. Its investment approach aims to generate attractive returns through a disciplined strategy and support for growth in portfolio companies and communities. For more information, visit the KKR website.
KKR Income Opportunities Fund (NYSE: KIO) declared monthly distributions of $0.1215 per share for June, with Ex-Date, Record Date, and Payable Date all falling on June 14, 2024. The distribution rate is provided for informational purposes only and does not indicate future results. Shareholders will receive a Form 1099-DIV for tax reporting purposes. Investors should carefully assess the Fund's objectives, risks, charges, and expenses before investing, as market conditions can impact the Fund's performance and distribution rate.